A study on the effect of tanshinone II A against human breast cancer in vivo

Journal of Sichuan University (Medical Science)

Volumn 41, Issue 1, 2010, Pages 62-67

  Zhang, Xin ^a,b   Zhang, Purong ^b   Chen, Jie ^a   Lü, Qing ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN CANCER HOSPITAL   (China)

Author keywords

Anti cancer apoptosis; Apoptosis; Breast cancer; Tanshinone II A

Indexed keywords

EID: 76249131776     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Yang Y, Deng CS. Pharmacological effect of tanshinone. J Hubei TCM, 1999;21 (6): 284-286.
2. Yuan SL, Huang RM, Wang XJ, et al. Reversing effeet of tanshinone on malignant phenotypes of human hepatocarcinoma cell line. World J Gastroenterology,1998;4(4):317-319.
3. Wang XJ. Wei UQ, Yu SL, et al. Potential anticancer activity of tanshinone II A against human breast cancer. Int J Cancer, 2005;116(5):799-807. (Pubitemid 41099713)
4. Volm M, Koomagi R, Mattern J. Prognostic value of Basic Fibrablast Growth Factor and its Receptor (FGFR-1) in patients with non-small cell lung carcinomas. European Journal of Cancer, 1997;33(4):691-693. (Pubitemid 27223759)
5. Kayaselcuk F, Nursal TZ, Polat A, et al. Expression of surviving, bcl-2, p53 and bax in breast carcinoma and ductal intraepithelial neoplasia(DIN 1α). J Exp Clin Cancer Res,2004; 23(1),105-112.
6. Thomadaki H, Scorilas A. Bcl-2 family of apoptosis-related genes, functions and clinical implications in cancer. Crit Rev Clin Lab Sci,2006;43(1):126-127.
7. Chearskul S, Onreabroi S, Churintrapun M, et al. Immunohistochemical study of c-erbB-2 expression in primarybreast cancer. Asian Pac J Allergy Immunol, 2001;19 (3): 197-205. (Pubitemid 34065334)